Investors who take an interest in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) should definitely note that the President, Jay Luly, recently paid US$5.69 per share to buy US$256k worth of the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback